why choose us

First received: July 19, 2022

Clinical Trial: Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects

Study Status: Completed

Recruit Status: Completed

Condition: Drug Use

Study Type: Interventional


Official Title: Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects

Brief Summary: The study was conducted toinvestigate whether the bioavailability of 3 mg Glimepiride Tablet Manufactured by PT. Harsen Laboratories was bioequivalent to the reference product, 3 mg Amaryl® Tablet Manufactured by PT. Aventis Indonesia Pharma, Indonesia.

Read more